ANDA 203335, held by Dr Reddys Labs SA. Aspirin; Butalbital; Caffeine; Codeine Phosphate.
As of Nov 15, 2026, ANDA 203335 (Butalbital, Aspirin, Caffeine, And Codeine Phosphate), held by Dr Reddys Labs SA, was first approved by FDA on Oct 30, 2015, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 30, 2015 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Butalbital, Aspirin, Caffeine, And Codeine Phosphate325MG;50MG;40MG;30MG ยท capsule;oral | Aspirin; Butalbital; Caffeine; Codeine Phosphate | Discontinued |
| Sep 18, 2018 | Supplement 5REMS | Approved | None posted |
| Oct 30, 2015 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters